
The Wall Street Journal @WSJ
U.S. drug regulators rejected Eli Lilly's proposed new Alzheimer's disease treatment, saying they need more data from clinical testing, according to the company https://t.co/8CNwGJ3lmC — PolitiTweet.org
Created
Fri Jan 20 00:10:05 +0000 2023
Likes
33
Retweets
11
Source
SocialFlow
View Raw Data
JSON DataView on Twitter
Likely AvailableThe Wall Street Journal @WSJ
U.S. drug regulators rejected Eli Lilly's proposed new Alzheimer's disease treatment, saying they need more data from clinical testing, according to the company https://t.co/8CNwGJ3lmC — PolitiTweet.org